The Anteris Technologies Ltd (ASX: AVR) share price took a hit today. This follows the company's latest announcement of a proposed capital raise.
The company's shares closed today's trade at $7.45, down 6.88%.
Anteris initiates capital raising
Anteris, a healthcare company specialising in the design and production of heart valve products, saw its share price fall after it announced a capital raise that will dilute existing shareholder value.
According to its release, Anteris advised it is placing 310,386 new ordinary shares mainly to its top 10 institutional shareholders.
The newly created shares will be offered at an issue price of $7.50 apiece, raising a total of $2.3 million.
The placement price represents a 9% discount to the 5-day volume weighted average price.
The shares will be issued using the company's existing placement capacity. Under listing rule 7.1, this allows up to 15% of its shares to be issued without shareholder approval.
In addition, participating investors will receive 1 unlisted option for every 2 shares, exercisable at $11.50 a pop.
The options will have a 2-year expiry period, and are subject to shareholder approval if they exceed listing rule 7.1.
Should shareholders vote against the issue of the options, the company will instead hand out a cash payment equivalent to $1.25 per option.
The vote will be held at Anteris' Annual General Meeting (AGM) in July.
The managers of the placement, Evolution Capital Advisors, will receive $81,739 for facilitating the capital raise.
Furthermore, there will be 50,000 options with the same terms available, pending shareholder approval. Again, should shareholders vote against, Anteris will pay a cash payment of $62,500 ($1.25 per option) to Evolution Capital Advisors.
About the Anteris share price
The Anteris share price is up just over 5% since this time last year.
Anteris shares reached a 52-week high of $13.75 in March, before treading lower due to profit taking and a broader market slump.
Based on today's price, Anteris has a market capitalisation of roughly $49 million, with only 6.6 million shares on issue.
